Peter Garcia
2022 - ALX ONCOLOGY HOLDINGS
In 2022, Peter Garcia earned a total compensation of $1.8M as Chief Financial Officer at ALX ONCOLOGY HOLDINGS, a 63% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $164,314 |
|---|---|
| Option Awards | $790,077 |
| Salary | $466,800 |
| Stock Awards | $332,630 |
| Total | $1,753,821 |
Garcia received $790.1K in option awards, accounting for 45% of the total pay in 2022.
Garcia also received $164.3K in non-equity incentive plan, $466.8K in salary and $332.6K in stock awards.
Rankings
In 2022, Peter Garcia's compensation ranked 1,966th out of 5,760 executives tracked by ExecPay. In other words, Garcia earned more than 65.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,966 out of 5,760 | 66th |
Division Manufacturing | 1,047 out of 3,136 | 67th |
Major group Chemicals And Allied Products | 445 out of 1,422 | 69th |
Industry group Drugs | 408 out of 1,323 | 69th |
Industry Pharmaceutical Preparations | 296 out of 969 | 70th |
Source: SEC filing on April 24, 2023.
Garcia's colleagues
We found two more compensation records of executives who worked with Peter Garcia at ALX ONCOLOGY HOLDINGS in 2022.
News
ALX ONCOLOGY HOLDINGS CEO Jason Lettmann receives $4.9M in 2023
April 22, 2024
ALX ONCOLOGY HOLDINGS CEO Jaume Pons' 2022 pay falls 63% to $3.7M
April 24, 2023
PDL BioPharma CEO Dominique Monnet's 2019 pay jumps 168% to $6.7M
July 7, 2020
PDL BioPharma CEO John McLaughlin's 2018 pay rises 20% to $4.1M
April 30, 2019